These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1070 related items for PubMed ID: 24913270

  • 1. The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Kramer JA, Grindley J, Crowell AM, Makaron L, Kohli R, Kirby M, Mansfield KG, Wachtman LM.
    Vet Pathol; 2015 Mar; 52(2):404-13. PubMed ID: 24913270
    [Abstract] [Full Text] [Related]

  • 2. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y, Fukusato T.
    World J Gastroenterol; 2014 Nov 14; 20(42):15539-48. PubMed ID: 25400438
    [Abstract] [Full Text] [Related]

  • 3. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y, Soejima Y, Fukusato T.
    World J Gastroenterol; 2012 May 21; 18(19):2300-8. PubMed ID: 22654421
    [Abstract] [Full Text] [Related]

  • 4. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
    Wu J.
    Oncotarget; 2016 Jul 05; 7(27):42762-42776. PubMed ID: 27072576
    [Abstract] [Full Text] [Related]

  • 5. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE, Poolman TM, Arvaniti A, Cox RD, Gathercole LL, Tomlinson JW.
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep 01; 319(3):G345-G360. PubMed ID: 32755310
    [Abstract] [Full Text] [Related]

  • 6. Histopathology, grading and staging of nonalcoholic fatty liver disease.
    Kleiner DE.
    Minerva Gastroenterol Dietol; 2018 Mar 01; 64(1):28-38. PubMed ID: 28948754
    [Abstract] [Full Text] [Related]

  • 7. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M, Bukong TN, Csak T, Saha B, Park JK, Ambade A, Kodys K, Szabo G.
    J Transl Med; 2015 Jun 16; 13():193. PubMed ID: 26077675
    [Abstract] [Full Text] [Related]

  • 8. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
    Kim TH, Jun HY, Kim KJ, Lee YH, Lee MS, Choi KH, Yun KJ, Jeong YY, Jun CH, Cho EY, Yoon KH.
    J Magn Reson Imaging; 2017 Nov 16; 46(5):1298-1310. PubMed ID: 28225569
    [Abstract] [Full Text] [Related]

  • 9. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec 16; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 10. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Brown GT, Kleiner DE.
    Metabolism; 2016 Aug 16; 65(8):1080-6. PubMed ID: 26775559
    [Abstract] [Full Text] [Related]

  • 11. [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis].
    Nakajima T, Naito H.
    Nihon Eiseigaku Zasshi; 2015 Aug 16; 70(3):197-204. PubMed ID: 26411937
    [Abstract] [Full Text] [Related]

  • 12. [Nonalcoholic fatty liver disease].
    Lemoine M, Serfaty L.
    Presse Med; 2012 Feb 16; 41(2):169-89. PubMed ID: 21723084
    [Abstract] [Full Text] [Related]

  • 13. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
    Lackner C.
    Expert Rev Gastroenterol Hepatol; 2011 Apr 16; 5(2):223-31. PubMed ID: 21476917
    [Abstract] [Full Text] [Related]

  • 14. Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.
    Ma DW, Arendt BM, Hillyer LM, Fung SK, McGilvray I, Guindi M, Allard JP.
    Nutr Diabetes; 2016 Jul 18; 6(7):e220. PubMed ID: 27428872
    [Abstract] [Full Text] [Related]

  • 15. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP, Rigbolt KTG, Veidal SS, Heebøll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Oró D, Thrane SW, Lund A, Strandberg C, Kønig MJ, Vilsbøll T, Vrang N, Thomsen KL, Grønbæk H, Jelsing J, Hansen HH, Knop FK.
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr 01; 316(4):G462-G472. PubMed ID: 30653341
    [Abstract] [Full Text] [Related]

  • 16. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M, Lappe S, Feldstein AE, Alkhouri N.
    Metabolism; 2016 Aug 01; 65(8):1161-71. PubMed ID: 26961580
    [Abstract] [Full Text] [Related]

  • 17. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y, Sugimoto K, Inui H, Fukusato T.
    World J Gastroenterol; 2015 Apr 07; 21(13):3777-85. PubMed ID: 25852263
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
    Tallino S, Duffy M, Ralle M, Cortés MP, Latorre M, Burkhead JL.
    J Nutr Biochem; 2015 Oct 07; 26(10):996-1006. PubMed ID: 26033743
    [Abstract] [Full Text] [Related]

  • 20. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
    Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, Sanyal AJ, Schwimmer JB, Lavine JE.
    Am J Gastroenterol; 2010 Sep 07; 105(9):2093-102. PubMed ID: 20372110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.